Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
GCM Grosvenor GCMG Stock Key Growth Drivers 301 20260418 Cellyan HKPD Stock Is It Ready for Entry Institutional Demand 20260418 Sow Good SOWG Sector Leadership Q3 2025 EPS Misses Views Public Storage PSA PreQ1 2026 Earnings Outlook Balancing Bullish Structural Tailwinds and NearTerm Headwinds for Investors FormFactor FORM Stock Key Catalysts Ahead Q4 2025 EPS Beats Forecasts Chemomab CMMB Stock Price Movement Smart Money Flows 20260420 Is Planet PL stock building strength Q1 2026 Earnings Underperform Immix Biopharma IMMX Q1 2026 Earnings 018 EPS Surges Past 021 Estimates Consumer Sentiment Plunges to Record Low as Iran War Drives Gas Prices Higher SurgePays SURG Reports Mixed Q4 2025 Revenue Beats but EPS Misses Creator Content Takes Center Stage at TV Upfronts as Advertisers Chase Younger Audiences CSLM KOYNU Stalls at 1025 Consolidation Phase 20260519 SRX Health SRXH Stock Jumps 400 Approaching 014 20260518 Intel Urges PC Makers to Embrace Advanced 18A Processors as AIDriven Semiconductor Demand Surges Consumer Sentiment Drops to Record Low in May on Surging Gas Prices Amid Iran Conflict EasyJet Assures Summer Operations Unaffected by Jet Fuel Supply Concerns Amid Iran Tensions Jim Cramer Suggests Potential Buying Opportunity in VF Corporation UK Gilt Yields Retreat from MultiDecade Highs as Political Calm Returns and Rate Outlook Softens RInfra Reports 79 Decline in Q4 Net Profit to 918 Crore Appoints Vijesh Babu Thota as CEO PENN Q1 2026 Earnings EPS Miss Widens as Costs Pressure Margins Shares Edge Higher Freedom Holding Corp Q1 2026 Earnings EPS of 125 Reported as Stock Declines Beazer Homes BZH Q1 2026 Earnings Surprise EPS Beat Defies Expectations Nomura Holdings Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment BMY Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Portfolio Strength Home Depot Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operating Trends ENDRA Life Sciences NDRA Shows Modest Gains Testing Resistance at 573 Silexion Therapeutics Warrants SLXNW Hold Steady at 002 Amid Thin Trading Citius Pharmaceuticals CTXR Slips 536 Amid Broader Biotech Weakness Rezolve AI Warrants RZLVW Edge Higher Navigating Support and Resistance Levels Miller Industries MLR Edges Higher as Shares Hold Steady Near Key Resistance Levels